PROFILPELAJAR.COM

Karazolol
(IUPAC) ime
	1-(9H-karbazol-4-iloksi)-3-(propan-2-ilamino)propan-2-ol
Klinički podaci
AHFS/Drugs.com	Internacionalno ime leka
Identifikatori
CAS broj	57775-29-8
ATCvet kod	QC07AA90
PubChem	71739
ChemSpider	64783
UNII	29PW75S82A
Hemijski podaci
Formula	C18H22N2O2
Mol. masa	298,38
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3 ; Key: BQXQGZPYHWWCEB-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Karazolol je antagonist/parcijalni inverzni agonist visokog afiniteta (beta blokator) β-adrenergičkog receptora.^[4]

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Innis RB, Corrēa FM, Synder SH (1979). „Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes”. Life Sci. 24 (24): 2255–64. DOI:10.1016/0024-3205(79)90102-4. PMID 41147.

	Portal Medicina
	Portal Hemija